Learn More
Medchemexpress LLC BSJ-04-122 | 2513289-74-0 | C15H12ClN5O | 5 MG

Supplier: Medchemexpress LLC HY1521855MG
BSJ-04-122 is a highly potent covalent dual inhibitor targeting MKK4 and MKK7, key kinases involved in cellular signaling pathways. It demonstrates strong inhibitory activity against MKK4 with an IC50 value of 4 nM and against MKK7 with an IC50 value of 181 nM. This compound is primarily utilized in cancer research, exhibiting its ability to induce a robust reduction in JNK phosphorylation.
- Potent covalent dual inhibitor of MKK4 and MKK7
- Inhibits MKK4 with an IC50 of 4 nM
- Inhibits MKK7 with an IC50 of 181 nM
- Induces robust reduction in JNK phosphorylation
- Enhances antiproliferative effects when combined with JNK-IN-8
- Useful for cancer research applications
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.